Results for tag: "Angelman Syndrome"

Angelman Syndrome (AS) is a rare neuro-genetic disorder that affects the nervous system. It is characterized by severe developmental delays, intellectual disability, motor dysfunction, and speech impairment. Healthcare services for AS are typically provided by a multidisciplinary team of specialists, including neurologists, geneticists, physical therapists, occupational therapists, speech-language pathologists, and psychologists. Treatment plans are tailored to the individual and may include physical, occupational, and speech therapy, as well as medications to manage seizures and other symptoms. In addition to medical care, AS patients and their families may benefit from a variety of support services, such as respite care, family counseling, and educational resources. These services can help families cope with the challenges of living with AS and provide them with the tools they need to ensure the best possible quality of life for their loved one. Companies in the AS market include Biomarin Pharmaceuticals, Inc., Ovid Therapeutics, Inc., and PTC Therapeutics, Inc. These companies are focused on developing treatments and therapies for AS, as well as providing support services for patients and their families. Show Less Read more